Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
bioAffinity Technologies, Inc. (BIAF) had Debt to Equity Ratio of 0.40 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$9.36M |
|
$-9.04M |
|
$5.98M |
|
$3.38M |
|
$18.32M |
|
$-8.95M |
|
$-0.07M |
|
$-9.03M |
|
$-9.03M |
|
$-9.04M |
|
$-9.04M |
|
$-9.04M |
|
$-9.04M |
|
$-8.95M |
|
$-8.35M |
|
0.40M |
|
0.40M |
|
$-22.52 |
|
$-22.52 |
|
| Balance Sheet Financials | |
$2.70M |
|
$0.38M |
|
$3.82M |
|
$6.51M |
|
$3.10M |
|
$0.46M |
|
$0.81M |
|
$3.91M |
|
$2.60M |
|
$0.42M |
|
$2.60M |
|
0.52M |
|
| Cash Flow Statement Financials | |
$-7.26M |
|
$-0.08M |
|
$5.63M |
|
$2.82M |
|
$1.11M |
|
$-1.72M |
|
$0.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.87 |
|
-- |
|
-- |
|
0.15 |
|
|
Debt to Equity Ratio |
0.40 |
36.09% |
|
-95.64% |
|
-95.64% |
|
-89.17% |
|
-96.43% |
|
-96.56% |
|
$-7.34M |
|
-- |
|
-- |
|
-- |
|
1.44 |
|
216.73 |
|
8.22 |
|
44.41 |
|
-347.41% |
|
-2140.06% |
|
-138.78% |
|
-294.78% |
|
$5.02 |
|
$-18.19 |
|
$-17.99 |
|